Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05569018 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy of a Transdiagnostic Group Treatment for Emotional Disorders Applied in Blended Format: a Controlled Study.

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Not Yet Recruiting to Recruiting
    • Primary and study completion dates: Jul 2025 to Jul 2027
    • Study sites: 0 to 1
    • Start date changed from estimate of Sep 2024 to Nov 23, 2024
    v6
  2. Start date: Jul 2024 to Sep 2024v5 Show 4 more changesShow less
    • Primary endpoints revised (2)
    • Primary and study completion dates: Jun 2025 to Jul 2025
    • Secondary endpoints: 5 to 8
    • Publications: 26 to 32
  3. Start date: Oct 2023 to Jul 2024v4
  4. Primary and study completion dates: Nov 2024 to Jun 2025
    • Start date: Feb 2023 to Oct 2023
    • Secondary endpoints: details revised at 5 of 5 entries
    v3
  5. Enrollment target: 159 to 144
    • Study description expanded, about 2 words
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Universitat Jaume I
21 trials monitored
See all monitored trials
Anxiety
3,263 trials monitored
See 159 trials at risk
Depression
3,055 trials monitored
See 173 trials at risk
This study will consist in a randomized controlled clinical trial (RCT) to test the efficacy of a blended group transversal protocol (BLGr-TP) compared to a face-to-face group transversal protocol (FFGr-TP). The main aims of the study are the following: * To analyze the differential efficacy of the BLGr-TP versus the FFGr-TP for the treatment of emotional disorders in aspects of clinical measures, as well as in terms of retention and dropout rate and adherence. * To analyze the differential acceptability of the BLGr-TP versus the FFGr-TP for the treatment of emotional disorders. In addition, it is intended to carry out a study of mediators and moderators of the efficacy of both interventions. The established hypotheses in relation to the main goals are: * Both treatment modalities (FFGr-TP and BLGr-TP) will achieve improvements in the symptoms of emotional disorders, reflected in the scores of the clinical measures. * The BLGr-TP will show equivalent efficacy to the FFGr-TP. * The BLGr-TP will show an acceptability comparable to the face-to-face protocol. Both modalities will be well valued by the participants. * In both treatment modalities, the changes achieved are expected to be maintained over time (3, 6 and 12 months).
Trial Details
NCT Number NCT05569018
Lead Sponsor Universitat Jaume I
Conditions
(from sponsor)		 Anxiety Disorders, Depressive Disorders
Related terms Anxiety Disorders, Depressive Disorder
Enrollment 144 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov